New study reveals way to predict side-effect risk from common immune suppressant medication: A major new study has found a method to identify people who may experience blood, kidney, or liver related side-effects from methotrexate, the most commonly used immune-suppressing medicine with 1.3 million users in the UK. The method, known as ‘risk stratification’, predicts […]
Read More… from Risk satisfaction to predict abnormal blood results
Webinar on community rheumatology: Spotlight on community rheumatology: experts debate the urgent need for reform in the UK. Under pressure rheumatology departments, a shortage of staff and the role community services can play in leading initial assessments and early treatment, will all be debated in the eagerly-anticipated ‘Community rheumatology services – now essential for 2022/23’ Connect Health […]
A new study, led by experts from the University of Nottingham, has shown that people with rare autoimmune rheumatic diseases are at a greater risk of dying at a younger age during the Covid-19 pandemic. The findings of the study, published in the British Society for Rheumatology’s journal, Rheumatology, was the work of a team […]
Read More… from People with rare autoimmune diseases at increased risk of dying during Covid-19
People with bone, joint and muscle pain saw their symptoms worsen during lockdown – according to new research from the University of East Anglia. A new study shows that the majority of people with musculoskeletal pain reported increased symptoms – as the nation adhered to new government restrictions designed to stop the spread of the […]